Legislation roundup: Foreign Pharma Investors, GBA Data Transfer, and Non-Performing Assets

Foreign marketing authorization holders are required to designate a domestic responsible person in China. Personal information handlers of the Greater Bay Area are required to make publicly available its rules for processing personal information. NFRA specifies the non-performing assets that a financial asset management company may acquire.

By Susan Mok

Healthcare

National Medical Products Administration, Tentative Provisions for the Administration of the Designation of a Domestic Responsible Person by Foreign Marketing Authorization Holders

国家药品监督管理局境外药品上市许可持有人指定境内责任人管理暂行规定

With respect to any one pharmaceutical product marketed in mainland China, the foreign marketing authorization holder shall designate a sole domestic responsible person therefor to perform the obligations of the marketing authorization holder.

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English

✓ Newsletters with business-critical and sector-specific updates

✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now